These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15197955)

  • 1. [Rapidly progressive glomerulonephritis].
    Yamagata K; Koyama A
    Nihon Rinsho; 2004 May; 62 Suppl 5():412-6. PubMed ID: 15197955
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvements in treatment strategies for patients with antineutrophil cytoplasmic antibody-associated rapidly progressive glomerulonephritis.
    Hotta O; Ishida A; Kimura T; Taguma Y
    Ther Apher Dial; 2006 Oct; 10(5):390-5. PubMed ID: 17096692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent advances of clinical and basic research in rapidly progressive glomerulonephritis].
    Yamagata K; Koyama A
    Nihon Rinsho; 2001 Sep; 59(9):1837-46. PubMed ID: 11554061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ANCA related (associated) glomerulonephritis].
    Arimura Y; Nagasawa T
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():461-70. PubMed ID: 11838154
    [No Abstract]   [Full Text] [Related]  

  • 5. Coexistence of anti-GBM antibodies and MPO-ANCA in a patient with systemic vasculitis and crescentic glomerulonephritis.
    Fernandes P; Lopes JA; Correia L; Gonçalves S; Jorge S
    Nefrologia; 2010; 30(6):709-10. PubMed ID: 21113229
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pulmonary-renal syndrome and Goodpasture's syndrome].
    Morita H; Ideura T
    Nihon Rinsho; 2004 May; 62 Suppl 5():421-5. PubMed ID: 15197957
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
    Okano K; Yumura W; Nitta K; Honda K; Uchida K; Nihei H
    Clin Nephrol; 2001 Apr; 55(4):275-81. PubMed ID: 11334312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic bronchiectasis and anti-myeloperoxidase antibody related rapidly progressive necrotizing glomerulonephritis.
    Pai P; Rustom R; Bone JM; Bell GM
    Clin Nephrol; 1998 Apr; 49(4):262-4. PubMed ID: 9582559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly progressive glomerulonephritis: current and evolving treatment strategies.
    Little MA; Pusey CD
    J Nephrol; 2004; 17 Suppl 8():S10-9. PubMed ID: 15599880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exchange in rapidly progressive glomerulonephritis.
    Cole E
    Prog Clin Biol Res; 1990; 337():257-62. PubMed ID: 2191318
    [No Abstract]   [Full Text] [Related]  

  • 11. Myeloperoxidase anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)-related rapidly progressive glomerulonephritis (RPGN) and pulmonary fibrosis (PF) with dissociated evolution.
    Souid M; Terki NH; Nochy D; Hillion D
    Clin Nephrol; 2001 Apr; 55(4):337-8. PubMed ID: 11334325
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rapidly progressive glomerulonephritis].
    Hirayama K; Yamagata K; Koyama A
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():436-46. PubMed ID: 11838150
    [No Abstract]   [Full Text] [Related]  

  • 13. [Etiology and therapy of acute progressive glomerulonephritis].
    Yamaguchi N; Muro K; Kikuchi S; Kobayashi M; Takahashi H; Koyama A
    Nihon Naika Gakkai Zasshi; 1998 Jul; 87(7):1254-62. PubMed ID: 9745273
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of CREST syndrome and myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.
    Yamashita K; Yorioka N; Kyuden Y; Naito T; Tanji C; Ueda C; Usui K; Shigemoto K; Harada S; Yamakido M
    Clin Nephrol; 2000 Apr; 53(4):296-300. PubMed ID: 10809419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Simultaneous presence of antibodies against the glomerular basement membrane and anti-myeloperoxidase antibodies in 2 patients with rapidly progressive glomerulonephritis].
    Díaz Rodríguez C; Costero O; Torre A; De Alvaro F; Gil F; Picazo ML; Martínez-Ara J
    Nefrologia; 2002; 22(2):190-5. PubMed ID: 12085420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rapidly progressive glomerulonephritis associated with myeloperoxidase specific-antineutrophil cytoplasmic antibody in patients with rheumatoid arthritis : report of three cases].
    Yoshihara R; Tanaka Y; Shiozawa K; Hayakawa M; Nagao M; Imura S
    Ryumachi; 1996 Oct; 36(5):762-8. PubMed ID: 8969556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four cases of anti-myeloperoxidase antibody-related rapidly progressive glomerulonephritis during the course of idiopathic pulmonary fibrosis.
    Hiromura K; Nojima Y; Kitahara T; Ueki K; Maezawa A; Kawai H; Yano S; Naruse T
    Clin Nephrol; 2000 May; 53(5):384-9. PubMed ID: 11305812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Yorioka N; Taniguchi Y; Amimoto D; Ogata S; Sakikubo E; Yamakido M; Naito T; Shimamoto F
    Clin Nephrol; 1999 Nov; 52(5):293-6. PubMed ID: 10584992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan.
    Muso E; Ito-Ihara T; Ono T; Imai E; Yamagata K; Akamatsu A; Suzuki K
    Jpn J Infect Dis; 2004 Oct; 57(5):S17-8. PubMed ID: 15507757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rapidly progressive glomerulonephritis].
    Yamagata K; Koyama A
    Nihon Naika Gakkai Zasshi; 2001 Nov; 90(11):2309-16. PubMed ID: 11769535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.